#wakeuptocorona
|
In the Netherlands, there are only a handful of laboratories that conduct safe research into the coronavirus. Thanks to thousands of donors of #wakeuptocorona, the LUMC was able to set up a second Biosafety Level 3 lab to study the coronavirus. The crowdfunding campaign enabled researchers in the university medical center to quickly scale up their research - in an (inter)national context - into virus inhibitors, medicines and vaccines. Crowdfunding continues, also with a view to the longer term. Molecular virologist Eric Snijder in a university news item about the Janssen vaccine:
Together against the virus The crowdfunding campaign #wakeuptcorona is an initiative of the Leiden University Fund in collaboration with the Bontius Foundation of the LUMC. The name #wakeuptocorona has its origins in the social media challenge in support of the action. |
|
Does your company have a gift match programme? Ask your employer to match your contribution and double your impact. |
Choose an amount
€ 50
#Wakeuptocorona
On behalf of LUMC’s researchers, a heartfelt thank you!
€ 250
#Wakeuptocorona
On behalf of LUMC’s researchers, a heartfelt thank you!
€ 1.000
#Wakeuptocorona
On behalf of LUMC’s researchers, a heartfelt thank you!
€ 5.000
#Wakeuptocorona
On behalf of LUMC’s researchers, a heartfelt thank you!
€ 7.500
#Wakeuptocorona
On behalf of LUMC's researchers, a heartfelt thank you!
Other
I want to choose my own amount
LUMC Center for Infectious Diseases
Leiden researchers began research into infectious diseases such as Ebola and SARS 25 years ago. With the knowledge that it has acquired, the LUMC has become the research and knowledge centre in the Netherlands in the field of infectious diseases.The LUMC is located at the Leiden Bio Science Park, where we collaborate with various international companies such as Janssen Pharmaceutica as well as with start-ups, and use is made of our test facilities. Internationally, our researchers work with various European partners.
Current research
Researchers from the LUMC are fighting the battle against coronavirus on multiple fronts. Below are the research projects that #wakeuptocorona donors have contributed to.
First of all, there is the research by Professor Eric Snijder and his team into virus inhibitors. With your support, a second Bio Safety Level 3 laboratory could be set up where the team can continue, accelerate and expand their research in a safe environment.
Led by Dr Marjolein Kikkert, the PREVENT nCoV-19 project is researching candidate vaccines. On this project, the vaccines are being tested in the lab and clinic for safety and effectiveness. The research is being carried out in collaboration with Leiden pharmaceutical company Janssen. The Janssen-Cilag International N.V COVID-19 vaccine has received authorization for emergency use by the European Medicines Agency (EMA) on March 11 2021. The vaccine was developed with fundamental support from the Molecular Virology group of the Leiden University Medical Centre.
Dutch paediatricians are collecting data on children who are hospitalised having contracted the virus. This is under the leadership of the LUMC’s Willem-Alexander Children’s Hospital. They want to find out more about the manifestation, progression and treatment of COVID-19 in children. This will help us protect children, and the adults around them, and will provide valuable input for policymakers.
The current COVID-19 vaccination campaign involves injecting the vaccine into muscle tissue, but injecting a smaller amount of vaccine in the skin might also provide good protection. The #wakeuptocorona crowdfunding campaign has enabled Anna Roukens (LUMC) to examine the safety and efficacy of vaccination delivery via the skin.
Finally, the researchers of the BEAT-COVID project are also very happy with the contribution from the crowdfunding campaign. This ambitious project, in which more than fifteen departments from the LUMC work together to better understand COVID-19, is unique in every respect. Doctors and researchers started a large study side in which improvement of care for the patient with Covid-19 is central. With this research they hope to be able to answer questions about the role of the immune system and factors that can predict the course of the disease in order to arrive at an individualized treatment of patients.
Look for current news on the News page on this website.
|
Does your company, fund or foundation want to help fight coronaviruses? Feel free to contact our relationship manager Ambika Lucassen at 071 526 57 49 about giving opportunities or read more about scientific research in the fight against coronavirus at Bontius Foundation | LUMC Research Foundation.
|
